Professional Certificate in Biomarker Discovery for Antimicrobial Therapies

-- ViewingNow
World-Class Certification
Trusted by Professionals Worldwide
Instant Enrollment ยท Start Today
4.0
Based on 3,532 reviews

6,510+

Students enrolled

£140

£202

Save 44% — Limited-Time Professional Rate

Start Now

InstantAccess ยท NoHiddenFees

MoneyBackGuarantee

RiskFreeEnrollment

SecureCheckout

EncryptedPayment

LifetimeAccess

LearnAtYourPace

์ด ๊ณผ์ •์— ๋Œ€ํ•ด

100% ์˜จ๋ผ์ธ

์–ด๋””์„œ๋“  ํ•™์Šต

๊ณต์œ  ๊ฐ€๋Šฅํ•œ ์ธ์ฆ์„œ

LinkedIn ํ”„๋กœํ•„์— ์ถ”๊ฐ€

์™„๋ฃŒ๊นŒ์ง€ 2๊ฐœ์›”

์ฃผ 2-3์‹œ๊ฐ„

์–ธ์ œ๋“  ์‹œ์ž‘

๋Œ€๊ธฐ ๊ธฐ๊ฐ„ ์—†์Œ

๊ณผ์ • ์„ธ๋ถ€์‚ฌํ•ญ

  • Introduction to Antimicrobial Resistance and the Need for Novel Therapies
  • Biomarker Discovery: Principles and Techniques (including genomics, proteomics, metabolomics)
  • Target Identification and Validation in Antimicrobial Drug Development
  • Preclinical Development of Biomarkers for Antimicrobial Therapies
  • Clinical Biomarker Development and Regulatory Considerations
  • Bioinformatics and Data Analysis for Antimicrobial Biomarker Discovery
  • Case Studies in Successful Antimicrobial Biomarker Discovery
  • Ethical Considerations in Biomarker Research and Development

๊ฒฝ๋ ฅ ๊ฒฝ๋กœ

Career Role in Biomarker Discovery (UK) Description Biomarker Scientist (Antimicrobial Therapies) Develops and validates novel biomarkers for antimicrobial drug discovery and development.

High demand for expertise in mass spectrometry and bioinformatics.

Clinical Research Associate (CRA) - Antimicrobial Focus Oversees clinical trials for new antimicrobial agents, contributing to biomarker data collection and analysis.

Requires strong GCP knowledge and experience in infectious disease.

Bioinformatician - Antimicrobial Data Analysis Analyzes large datasets generated from biomarker studies, identifying patterns and trends relevant to antimicrobial resistance.

Expertise in statistical modeling crucial.

Pharmaceutical Scientist - Antimicrobial Development Contributes to the development and characterization of novel antimicrobial drugs, employing biomarker data for drug efficacy and safety assessment.

Experience in formulation and drug delivery systems is highly desirable.

์ž…ํ•™ ์š”๊ฑด

  • ์ฃผ์ œ์— ๋Œ€ํ•œ ๊ธฐ๋ณธ ์ดํ•ด
  • ์˜์–ด ์–ธ์–ด ๋Šฅ์ˆ™๋„
  • ์ปดํ“จํ„ฐ ๋ฐ ์ธํ„ฐ๋„ท ์ ‘๊ทผ
  • ๊ธฐ๋ณธ ์ปดํ“จํ„ฐ ๊ธฐ์ˆ 
  • ๊ณผ์ • ์™„๋ฃŒ์— ๋Œ€ํ•œ ํ—Œ์‹ 

์‚ฌ์ „ ๊ณต์‹ ์ž๊ฒฉ์ด ํ•„์š”ํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค. ์ ‘๊ทผ์„ฑ์„ ์œ„ํ•ด ์„ค๊ณ„๋œ ๊ณผ์ •.

๊ณผ์ • ์ƒํƒœ

์ด ๊ณผ์ •์€ ๊ฒฝ๋ ฅ ๊ฐœ๋ฐœ์„ ์œ„ํ•œ ์‹ค์šฉ์ ์ธ ์ง€์‹๊ณผ ๊ธฐ์ˆ ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ๊ทธ๊ฒƒ์€:

  • ์ธ์ •๋ฐ›์€ ๊ธฐ๊ด€์— ์˜ํ•ด ์ธ์ฆ๋˜์ง€ ์•Š์Œ
  • ๊ถŒํ•œ์ด ์žˆ๋Š” ๊ธฐ๊ด€์— ์˜ํ•ด ๊ทœ์ œ๋˜์ง€ ์•Š์Œ
  • ๊ณต์‹ ์ž๊ฒฉ์— ๋ณด์™„์ 

๊ณผ์ •์„ ์„ฑ๊ณต์ ์œผ๋กœ ์™„๋ฃŒํ•˜๋ฉด ์ˆ˜๋ฃŒ ์ธ์ฆ์„œ๋ฅผ ๋ฐ›๊ฒŒ ๋ฉ๋‹ˆ๋‹ค.

์™œ ์‚ฌ๋žŒ๋“ค์ด ๊ฒฝ๋ ฅ์„ ์œ„ํ•ด ์šฐ๋ฆฌ๋ฅผ ์„ ํƒํ•˜๋Š”๊ฐ€

๋ฆฌ๋ทฐ ๋กœ๋”ฉ ์ค‘...

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

์ด ๊ณผ์ •์„ ๋‹ค๋ฅธ ๊ณผ์ •๊ณผ ๊ตฌ๋ณ„ํ•˜๋Š” ๊ฒƒ์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

▼

๊ณผ์ •์„ ์™„๋ฃŒํ•˜๋Š” ๋ฐ ์–ผ๋งˆ๋‚˜ ๊ฑธ๋ฆฌ๋‚˜์š”?

▼

WhatSupportWillIReceive

▼

IsCertificateRecognized

▼

WhatCareerOpportunities

▼

์–ธ์ œ ์ฝ”์Šค๋ฅผ ์‹œ์ž‘ํ•  ์ˆ˜ ์žˆ๋‚˜์š”?

▼

์ฝ”์Šค ํ˜•์‹๊ณผ ํ•™์Šต ์ ‘๊ทผ ๋ฐฉ์‹์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

▼

์ฝ”์Šค ์ˆ˜๊ฐ•๋ฃŒ

๊ฐ€์žฅ ์ธ๊ธฐ
๋น ๋ฅธ ๊ฒฝ๋กœ: £140
1๊ฐœ์›” ๋‚ด ์™„๋ฃŒ
๊ฐ€์† ํ•™์Šต ๊ฒฝ๋กœ
  • ์ฃผ 3-4์‹œ๊ฐ„
  • ์กฐ๊ธฐ ์ธ์ฆ์„œ ๋ฐฐ์†ก
  • ๊ฐœ๋ฐฉํ˜• ๋“ฑ๋ก - ์–ธ์ œ๋“ ์ง€ ์‹œ์ž‘
Start Now
ํ‘œ์ค€ ๋ชจ๋“œ: £90
2๊ฐœ์›” ๋‚ด ์™„๋ฃŒ
์œ ์—ฐํ•œ ํ•™์Šต ์†๋„
  • ์ฃผ 2-3์‹œ๊ฐ„
  • ์ •๊ธฐ ์ธ์ฆ์„œ ๋ฐฐ์†ก
  • ๊ฐœ๋ฐฉํ˜• ๋“ฑ๋ก - ์–ธ์ œ๋“ ์ง€ ์‹œ์ž‘
Start Now
๋‘ ๊ณ„ํš ๋ชจ๋‘์— ํฌํ•จ๋œ ๋‚ด์šฉ:
  • ์ „์ฒด ์ฝ”์Šค ์ ‘๊ทผ
  • ๋””์ง€ํ„ธ ์ธ์ฆ์„œ
  • ์ฝ”์Šค ์ž๋ฃŒ
์˜ฌ์ธํด๋ฃจ์‹œ๋ธŒ ๊ฐ€๊ฒฉ โ€ข ์ˆจ๊ฒจ์ง„ ์ˆ˜์ˆ˜๋ฃŒ๋‚˜ ์ถ”๊ฐ€ ๋น„์šฉ ์—†์Œ

๊ณผ์ • ์ •๋ณด ๋ฐ›๊ธฐ

์ƒ์„ธํ•œ ์ฝ”์Šค ์ •๋ณด๋ฅผ ๋ณด๋‚ด๋“œ๋ฆฌ๊ฒ ์Šต๋‹ˆ๋‹ค

ํšŒ์‚ฌ๋กœ ์ง€๋ถˆ

์ด ๊ณผ์ •์˜ ๋น„์šฉ์„ ์ง€๋ถˆํ•˜๊ธฐ ์œ„ํ•ด ํšŒ์‚ฌ๋ฅผ ์œ„ํ•œ ์ฒญ๊ตฌ์„œ๋ฅผ ์š”์ฒญํ•˜์„ธ์š”.

์ฒญ๊ตฌ์„œ๋กœ ๊ฒฐ์ œ

๊ฒฝ๋ ฅ ์ธ์ฆ์„œ ํš๋“

์ƒ˜ํ”Œ ์ธ์ฆ์„œ ๋ฐฐ๊ฒฝ
PROFESSIONAL CERTIFICATE IN BIOMARKER DISCOVERY FOR ANTIMICROBIAL THERAPIES
์—๊ฒŒ ์ˆ˜์—ฌ๋จ
ํ•™์Šต์ž ์ด๋ฆ„
์—์„œ ํ”„๋กœ๊ทธ๋žจ์„ ์™„๋ฃŒํ•œ ์‚ฌ๋žŒ
London School of International Business (LSIB)
์ˆ˜์—ฌ์ผ
05 May 2025
๋ธ”๋ก์ฒด์ธ ID: s-1-a-2-m-3-p-4-l-5-e
์ด ์ž๊ฒฉ์ฆ์„ LinkedIn ํ”„๋กœํ•„, ์ด๋ ฅ์„œ ๋˜๋Š” CV์— ์ถ”๊ฐ€ํ•˜์„ธ์š”. ์†Œ์…œ ๋ฏธ๋””์–ด์™€ ์„ฑ๊ณผ ํ‰๊ฐ€์—์„œ ๊ณต์œ ํ•˜์„ธ์š”.
์ƒˆ ๋“ฑ๋ก
4.8

Wait! Don't miss out

Save 44% on all courses โ€” our biggest discount this year.

Browse Courses Now